Effects of iminodipropionitrile on cerebral amino acid levels

Brain Research Bulletin
E TóthE S Vizi

Abstract

Iminodipropionitrile (IDPN), a compound that causes dyskinetic symptoms in animals and has possible use as a model for human dyskinesia, was tested in mice and rats for its effect on cerebral amino acids. In mice, 2 h after IDPN administration, the level of total brain alanine was reduced; after 5 h the levels of aspartic acid and glutamic acid were also reduced, and the level of glutamine was increased. In rats, after chronic administration of IDPN, the level of glutamic acid in the total brain tissue was reduced. After acute administration of IDPN using microdialysis, extracellular GABA and extracellular glutamine levels in the striatum were elevated. This study shows that IDPN causes alterations in total and extracellular levels of neurotransmitter amino acids in the brain, which could have a role in IDPN-induced dyskinesia.

References

Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jan 1, 1968·International Journal of Neuropharmacology·J K TewsW E Stone
Jan 1, 1983·Advances in Neurology·S Fahn
Dec 1, 1984·Neuropharmacology·A R Green
Jun 1, 1984·Experimental Neurology·J S Schneider
Mar 1, 1993·Neurotoxicology and Teratology·K M CroftonM E Stanton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.